Member News

Doudna wins Priestley Medal

ASBMB Staff
By ASBMB Staff
Oct. 6, 2025

Jennifer Doudna has been awarded the prestigious 2026 Joseph Priestley Medal for her groundbreaking work on RNA molecules with enzymatic functions by the American Chemical Society. This medal is the highest honor given by ACS and recognizes distinguished scientists in chemistry. Specifically, ACS cited her work on ribozyme function, Dicer, double-stranded RNA processing and CRISPR–Cas9 gene editing. Doudna will receive a $20,000 research grant.  In 1774, Joseph Priestley, an English scientist and political dissident, discovered oxygen, which answered fundamental questions about combustion and led him to continue his scientific work in America after his political views made it unsafe for him to remain in England.

Jennifer Doudna

Doudna is a faculty scientist at the Lawrence Berkely National Laboratory, founder of the Innovative Genomics Institute, a professor at UC Berkeley and an investigator with the Howard Hughes Medical Institute. Her lab investigates RNA as it forms a variety of complex globular structures, some of which function like enzymes or form functional complexes with proteins.

Previous awards include the 2025 National Medal of Technology and Innovation, presented by former President Joe Biden in January for her work on work on CRISPR–Cas9 gene editing, as well as the 2020 Nobel Prize in Chemistry alongside Emmanuelle Charpentier. She is a member of the National Academy of Sciences, the National Academy of Medicine, the National Academy of Inventors and the American Academy of Arts and Sciences. Doudna is also a Foreign Member of the Royal Society and has received numerous other honors, including the Breakthrough Prize in Life Sciences, the Japan Prize, the Kavli Prize, the LUI Che Woo Welfare Betterment Prize and the Wolf Prize in Medicine.

“Jennifer’s career and discoveries have been nothing short of phenomenal,” Michael Marletta, professor of chemistry and molecular and cell biology at the University of California, Berkeley, said in the ACS press release. “She is a national and international leader in science. She is a strong and visible role model for women across the globe. She leads by her devoted mentorship to her students and postdocs. Her leadership in charting a course for the ethical use of gene editing has been essential.”

She will formally accept the award and deliver remarks at the ACS Spring 2026 conference.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Staff
ASBMB Staff

This article was written by a member or members of the American Society for Biochemistry and Molecular Biology staff.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Exploring the link between lipids and longevity
Profile

Exploring the link between lipids and longevity

Jan. 2, 2026

Meng Wang will present her work on metabolism and aging at the ASBMB Annual Meeting, March 7-10, just outside of Washington, D.C.

Defining a ‘crucial gatekeeper’ of lipid metabolism
Award

Defining a ‘crucial gatekeeper’ of lipid metabolism

Dec. 31, 2025

George Carman receives the Herbert Tabor Research Award at the ASBMB Annual Meeting, March 7–10, just outside of Washington, D.C.

Nuñez receives Vallee Scholar Award
Member News

Nuñez receives Vallee Scholar Award

Dec. 29, 2025

He will receive $400,000 to support his research.

Mydy named Purdue assistant professor
Member News

Mydy named Purdue assistant professor

Dec. 22, 2025

Her lab will focus on protein structure and function, enzyme mechanisms and plant natural product biosynthesis, working to characterize and engineer plant natural products for therapeutic and agricultural applications.

In memoriam: Michael J. Chamberlin
In Memoriam

In memoriam: Michael J. Chamberlin

Dec. 15, 2025

He discovered RNA polymerase and was an ASBMB member for nearly 60 years.

Building the blueprint to block HIV
Profile

Building the blueprint to block HIV

Dec. 11, 2025

Wesley Sundquist will present his work on the HIV capsid and revolutionary drug, Lenacapavir, at the ASBMB Annual Meeting, March 7–10, in Maryland.